Compare Stocks: QSI, EVO, OABI, and CTKB

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTKB Cytek Biosciences	$4.70	$4.55	$3.28 ▼ $6.18	$610.92M	1.18	780,272 shs	478,226 shs
EVO Evotec	$1.86 -2.1%	$2.15	$1.80 ▼ $4.27	$661.82M	1.92	46,725 shs	121,906 shs
OABI OmniAb	$4.33 -8.8%	$2.99	$1.30 ▼ $5.43	$626.91M	0.62	2.62 million shs	1.70 million shs
QSI Quantum-Si	$0.77 +0.7%	$0.81	$0.69 ▼ $3.10	$167.66M	3.25	2.80 million shs	896,354 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTKB Cytek Biosciences	0.00%	+0.43%	+12.98%	+14.91%	+19.29%
EVO Evotec	0.00%	-2.62%	-4.62%	-33.57%	-45.93%
OABI OmniAb	0.00%	-3.13%	+93.30%	+74.60%	+184.87%
QSI Quantum-Si	0.00%	-1.79%	+1.46%	-27.05%	-28.41%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTKB Cytek Biosciences	$4.70	$4.55	$3.28 ▼ $6.18	$610.92M	1.18	780,272 shs	478,226 shs
EVO Evotec	$1.86 -2.1%	$2.15	$1.80 ▼ $4.27	$661.82M	1.92	46,725 shs	121,906 shs
OABI OmniAb	$4.33 -8.8%	$2.99	$1.30 ▼ $5.43	$626.91M	0.62	2.62 million shs	1.70 million shs
QSI Quantum-Si	$0.77 +0.7%	$0.81	$0.69 ▼ $3.10	$167.66M	3.25	2.80 million shs	896,354 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTKB Cytek Biosciences	0.00%	+0.43%	+12.98%	+14.91%	+19.29%
EVO Evotec	0.00%	-2.62%	-4.62%	-33.57%	-45.93%
OABI OmniAb	0.00%	-3.13%	+93.30%	+74.60%	+184.87%
QSI Quantum-Si	0.00%	-1.79%	+1.46%	-27.05%	-28.41%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CTKB Cytek Biosciences	2.33	Hold	$5.56	18.35% Upside
EVO Evotec	2.00	Hold	$3.00	61.29% Upside
OABI OmniAb	2.33	Hold	$11.00	154.04% Upside
QSI Quantum-Si	2.00	Hold	$1.00	30.55% Upside

Current Analyst Ratings Breakdown

Latest QSI, EVO, OABI, and CTKB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	EVO Evotec	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/25/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	OABI OmniAb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/17/2026	OABI OmniAb	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$11.00
8/14/2026	QSI Quantum-Si	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/11/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/7/2026	CTKB Cytek Biosciences	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$5.00
8/6/2026	OABI OmniAb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/21/2026	EVO Evotec	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/21/2026	OABI OmniAb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/21/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CTKB Cytek Biosciences	$206.71M	2.96	N/A	N/A	$2.48 per share	1.90
EVO Evotec	$891.97M	0.74	N/A	N/A	$2.17 per share	0.86
OABI OmniAb	$38.46M	16.30	N/A	N/A	$1.80 per share	2.41
QSI Quantum-Si	$2.44M	68.71	N/A	N/A	$0.82 per share	0.93

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CTKB Cytek Biosciences	-$66.54M	-$0.62	N/A	N/A	N/A	-38.98%	-12.40%	-9.17%	11/4/2026 (Estimated)
EVO Evotec	-$117.12M	N/A	N/A	46.50	N/A	-26.20%	-24.93%	-11.35%	11/5/2026 (Estimated)
OABI OmniAb	-$64.78M	-$0.36	N/A	N/A	N/A	-115.12%	-16.59%	-14.82%	11/3/2026 (Estimated)
QSI Quantum-Si	-$101.34M	-$0.46	N/A	N/A	N/A	-6,138.26%	-47.12%	-43.18%	11/4/2026 (Estimated)

Latest QSI, EVO, OABI, and CTKB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	QSI Quantum-Si	-$0.1133	-$0.11	+$0.0033	-$0.11	$0.30 million	$0.34 million
8/6/2026	Q2 2026	OABI OmniAb	-$0.12	-$0.05	+$0.07	-$0.05	$4.69 million	$13.42 million
8/5/2026	Q2 2026	CTKB Cytek Biosciences	-$0.0933	-$0.09	+$0.0033	-$0.09	$47.31 million	$48.14 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CTKB Cytek Biosciences	N/A	N/A	N/A	N/A	N/A
EVO Evotec	N/A	N/A	N/A	N/A	N/A
OABI OmniAb	N/A	N/A	N/A	N/A	N/A
QSI Quantum-Si	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CTKB Cytek Biosciences	N/A	4.48	3.86
EVO Evotec	0.62	2.33	2.21
OABI OmniAb	N/A	4.80	4.80
QSI Quantum-Si	N/A	9.97	9.80

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CTKB Cytek Biosciences	69.46%
EVO Evotec	5.81%
OABI OmniAb	72.08%
QSI Quantum-Si	39.90%

Insider Ownership

Company	Insider Ownership
CTKB Cytek Biosciences	10.36%
EVO Evotec	1.00%
OABI OmniAb	9.80%
QSI Quantum-Si	22.04%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CTKB Cytek Biosciences	500	129.98 million	116.52 million	Optionable
EVO Evotec	4,553	355.82 million	352.26 million	Not Optionable
OABI OmniAb	7	144.78 million	130.59 million	Optionable
QSI Quantum-Si	150	218.88 million	170.64 million	Optionable

QSI, EVO, OABI, and CTKB Headlines

Recent News About These Companies

Quantum‑Si Earnings Call: Proteus Delay, Runway Extended

August 22, 2026 | theglobeandmail.com

Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

August 18, 2026 | globenewswire.com

FY2026 EPS Estimates for Quantum-Si Lifted by HC Wainwright

August 18, 2026 | marketbeat.com

Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

Quantum-Si Q2 Earnings Call Highlights

August 13, 2026 | marketbeat.com

Quantum-Si Incorporated (QSI) Reports Q2 Loss, Tops Revenue Estimates

August 13, 2026 | zacks.com

Quantum-Si (NASDAQ:QSI) Announces Quarterly Earnings Results

August 13, 2026 | marketbeat.com

Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update

August 13, 2026 | globenewswire.com

Stock Traders Purchase Large Volume of Call Options on Quantum-Si (NASDAQ:QSI)

August 13, 2026 | marketbeat.com

Quantum-Si Q2 2026 earnings preview

August 12, 2026 | msn.com

Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026

July 27, 2026 | globenewswire.com

Why Quantum-Si incorporated’s (QSI) Stock Is Up 5.02%

July 1, 2026 | aaii.comA

Quantum-Si (NASDAQ:QSI) CEO Jeffrey Alan Hawkins Sells 11,311 Shares

June 25, 2026 | insidertrades.com

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 16, 2026 | businesswire.com

Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™

June 10, 2026 | rutlandherald.comR

Why Quantum-Si incorporated’s (QSI) Stock Is Down 7.81%

June 8, 2026 | aaii.comA

Quantum-Si Announces the Expansion of the Proteus™ Roadshow

June 3, 2026 | finance.yahoo.com

Quantum-Si Announces the Expansion of the Proteus™ Roadshow

June 3, 2026 | businesswire.com

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?

June 1, 2026 | finance.yahoo.com

Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript

May 15, 2026 | seekingalpha.com

Alliance Global Partners Sticks to Its Buy Rating for Quantum-Si (QSI)

May 14, 2026 | theglobeandmail.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

QSI, EVO, OABI, and CTKB Company Descriptions

Cytek Biosciences NASDAQ:CTKB

$4.70 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Evotec NASDAQ:EVO

$1.86 -0.04 (-2.11%)

As of 09/4/2026 04:00 PM Eastern

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

OmniAb NASDAQ:OABI

$4.33 -0.42 (-8.84%)

As of 09/4/2026 04:00 PM Eastern

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

Quantum-Si NASDAQ:QSI

$0.77 +0.01 (+0.66%)

As of 09/4/2026 04:00 PM Eastern

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest QSI, EVO, OABI, and CTKB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest QSI, EVO, OABI, and CTKB Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

QSI, EVO, OABI, and CTKB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

QSI, EVO, OABI, and CTKB Company Descriptions

Cytek Biosciences NASDAQ:CTKB

Evotec NASDAQ:EVO

OmniAb NASDAQ:OABI

Quantum-Si NASDAQ:QSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest QSI, EVO, OABI, and CTKB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest QSI, EVO, OABI, and CTKB Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

QSI, EVO, OABI, and CTKB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

QSI, EVO, OABI, and CTKB Company Descriptions

Cytek Biosciences NASDAQ:CTKB

Evotec NASDAQ:EVO

OmniAb NASDAQ:OABI

Quantum-Si NASDAQ:QSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools